Scripts Data Indicates Biogen's (BIIB) Tecfidera Could Beat 2013 Estimates by $400M
Tweet Send to a Friend
This morning IMS reported scripts data for Biogen's (NASDAQ: BIIB) Tecfidera. So far 1998 prescriptions have been generated in less ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
